Inventaire - your friends and communities are your best library

Treatment of Dravet Syndrome

published in: Canadian Journal of Neurological Sciences

date of publication: 2016-06-01

Cites articles 40

Date

Title

Authors

2015-04-03

Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
2015-04-06

Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan
2014-09-17

Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children

Alexis Arzimanoglou, Paul Boon, Sophia Varadkar
2014-01-07

Sleep abnormalities in children with Dravet syndrome.
2014-10-28

Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen

Anastasia Dressler, Angelika Mühlebner
2014-02-19

Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence
2014-05-10

Effect of CYP2C19 polymorphisms on stiripentol administration in Japanese cases of Dravet syndrome

Shinichi Hirose, Kazuhiro Yamakawa
2013-11-13

Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy

Giulia Barcia, Catherine Chiron
2013-07-12

Stiripentol in Dravet syndrome: results of a retrospective U.S. study

Orrin Devinsky, Mohamad A. Mikati
2013-09-01

Stiripentol in refractory status epilepticus
2013-05-07

The ketogenic diet in Dravet syndrome
2012-11-29

Effect of vagus nerve stimulation in an adult patient with Dravet syndrome: contribution to sudden unexpected death in epilepsy risk reduction?

Andrea O Rossetti
2012-07-10

Dravet syndrome: seizure control and gait in adults with different SCN1A mutations
2012-05-03

Successful use of fenfluramine as an add-on treatment for Dravet syndrome.
2012-07-01

Progressive gait deterioration in adolescents with Dravet syndrome.

Ingrid Scheffer, Samuel Berkovic, Jacinta M McMahon
2012-02-01

Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome
2011-04-01

Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet
2011-04-01

Dravet syndrome and parent associations: the IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief
2011-04-01

The effects of stiripentol on GABA(A) receptors
2011-11-02

Dravet syndrome--considerable delay in making the diagnosis

Karl Otto Nakken
2011-05-28

Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome

Giangennaro Coppola
2011-04-01

Overall management of patients with Dravet syndrome
2011-05-13

Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study

Catherine Chiron
2010-10-23

Clinical course of young patients with Dravet syndrome after vagal nerve stimulation
2010-02-20

Unusual consequences of status epilepticus in Dravet syndrome

Nathalie Boddaert, Catherine Chiron
2009-01

The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator
2009-05-01

Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction
2008-11-01

Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome)--a nationwide questionnaire survey in Japan
2008-07-25

Vagus nerve stimulation in pediatric epileptic syndromes
2007-11-19

Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data

Renzo Guerrini
2007-04-01

Dramatic response to levetiracetam in post-ischaemic Holmes' tremor

Fabio Tortora, Federico Zara
2007-07-01

An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy

Nicola Specchio, Maurizio Elia, Tiziana Granata, Federico Zara

Article - wd:Q38855474

Welcome to Inventaire

the library of your friends and communities

learn more